For example, AstraZeneca (AZ) has recently signed an exclusive license agreement with Eccogene granting it certain exclusive global rights for Eccogenes oral GLP-1RA drug in development
Draw Your Dose: Insert the syringe tip into the adapter, then flip the bottle and syringe upside down while holding them together
Improvements in other health markers, such as blood pressure, cholesterol, and blood sugar, were also experienced by most participants
Until these trials report and a regulator reviews them, every retatrutide result remains investigational, with no approval date
In clinical research, patient variability manifests in several forms
March 25, 2025: Food & Drug Administration Says Trulicity Shortage Still Active as Lawsuits Increase On February 21, 2025, the Food & Drug Administration lifted many of the semaglutide injection shortages